More vaccine updates
Yesterday, Russia announced that the first phase 3 trial interim analysis of their Sputnik V COVID-19 vaccine showed 92% efficiency, but many questions remain. Meanwhile, Moderna announced that they would be…
Yesterday, Russia announced that the first phase 3 trial interim analysis of their Sputnik V COVID-19 vaccine showed 92% efficiency, but many questions remain. Meanwhile, Moderna announced that they would be…
Testy szczepionki przeciw Covid-19 stworzonej przez naukowców z Uniwersytetu Oksfordzkiego i koncern farmaceutyczny AstraZeneca, które w minionym tygodniu wstrzymano ze względu na możliwy efekt uboczny, mogą zostać wznowione - poinformowano…
Experts increasingly nervous as Alberta COVID-19 cases climb Alberta is seeing the highest daily increases in active COVID-19 cases since April, putting infectious disease experts, doctors and politicians on edge. Thirteen…
Health experts in Montreal — including ER doctors, epidemiologists and infectious disease specialists — are getting haircuts again and hanging out with friends, but many said it will take a…
Although there has been plenty of research linking mortality to various habits and lifestyle factors, scientists at the University of British Columbia (UBC) in Vancouver, Canada — in collaboration with…